Cite

    Yi Dong et al.. “Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.” Stroke and vascular neurology, vol. 5, no. 4, 2020, pp. 348–352. http://access.bl.uk/ark:/81055/vdc_100127565734.0x000018